Human papillomavirus (HPV) is the primary cause of 99.7% of all cervical cancers in Kenya and 70% in the world(statistics of year 2013).
This makes it highly preventable.
Cervical cancer is the second highest common cancer in women in the world.
By staying away from Human papilloma virus one can eliminate about 99.7% chances of getting the cancer.
Below are some of the methods of preventing cervical cancerr.
- Promote abstinence or delayed sexual debut for adolescents.
- Promote faithfulness to one partner for those in relationships
- Promote Condom use: Allows faster HPV clearance, increases regression of cervical lesions, reduces the risk of genital warts as well as pre-cancer and cancer, protects against other STIs that are cofactors for cervical cancer, and protects against HIV which facilitates high risk HPV infection and progression into high grade squamous intraepithelial lesion.
- Promote HPV Vaccination.
- Promote male circumcision. Circumcision prevents HIV infection by about 60%.
HPV Vaccination(primary prevention)
At present, two types of HPV vaccines are available: One type that protects against the high risk HPV types 16 and 18 as well as low risk types 6 and 11 that are responsible for genital warts and another type which protects against HPV types 16 and18.
Both vaccines are licensed for use in Kenya.
The vaccines should be given to even to the girls of age 9-13 years and to women of 26 years. At least women should get this vaccine in their lifetime.
Cancer has a long period(latency) of up to 10years before it is full blown(precancerous period).
Secondary prevention aims at preventing the precancer to becoming invasive cancer.
Screening and Early Diagnosis.
The methods below are used to screening of cervical cancer.
- Visual inspection with acetic acid (VIA)
- Visual inspection with Lugol’s iodine (VILI)
- Cytology using conventional and liquid based Pap smear
- HPV testing
Early sexual exposure, multiple sexual partners and previous abnormal screening results are at high risk of cervical abnormalies.
Screening should be done after every 5 years and more frequent for those with HIV or those with abnormal test results whose screening should be done yearly.
Screenining should be stopped when patient is 65 years.
Screening for HIV positive women
All HIV positive women above 18 years shold be screened for cervical cancer after every six months in the first year and then yearly.
Screening during Pregnancy and Puerperium(period of about one month after giving birth)
It is recommended that screening should be done for the first 20 weeks of pregnancy.
No treament should be given to non-invasive cervical cancer inless there is evidence of spread.
Patients should return 6-12 weeks after giving birth.
Screenning will be handled as follows for Visual inspection with acetic(VIA) acid orLugols Iodine (VILI).
Negative cases shoul wait fo five years for another test.
Positive cases should be treated vappropriately.
Those found suspicious should be tested further using biopsy and colposcopy.
Methods of Treatment of Precancerous Cervical Lesions
This method involves freezing abnormal tissues with a probe cooled by liquid nitrous oxide or carbon dioxide.
It has an overall effectiveness rate of 80-90% in women with suitable lesions. It is simple, safe, and major complications are uncommon.
It is also inexpensive; does not require electricity, and is practical for low-resource settings.
It has been safely performed by nurses and other non-physicians in low level facilities and even primary care level in Kenya and elsewhere.
Common Symptoms and Signs of Invasive Cervical Cancer.
- Vaginal discharge, sometimes foul smelling
- Irregular vaginal bleeding
- Post coital bleeding(bleeding after sex) in women of any age
- Post menopausal bleeding (especially that which does not respond to appropriate treatment)
- Urinary frequency and urgency
- Lower abdominal pain
- Severe back pain
- Weight loss
- Oliguria(low urine volume) (due to ureteric obstruction or renal(kidney) failure)
- Urinary/fecal incontinence
- Edema of lower limbs
- Dyspnoea(shorness of breath) (due to anemia, metastasis or pleural effusion)
Treatment options depend on stage of the cancer and include radiotherapy, surgery, or chemotherapy or a combination of any.
The cancer managerial team shoul decide what is the best treament for the patient.
In pregnancy, the treatment is individualized on basis of risk benefit ratio.
Outcome of cervical cancer
The outcome of cervical cancer depends on early diagnosis and treatment.
If diagnosis and treatment is done in early stages recovery rate is between 95-98%.
In very late stages the recovery rate is 5-10%.
you might also like
- Lung Cancer |signs, Prevention and treatment
- Oesophageal Cancer
- Acute Leukaemia |blood cancer
- skin cancer |prevention and treatment
- Kaposi’s Sarcoma | human herpes virus 8(HHV8) cancer
- Nephroblastoma |Wilm’s Tumour
- Biliary Tract Cancer
- Endometrial Cancer
- Colon Cancer
- breast cancer | the leading cause of cancer related deaths in women